Literature DB >> 3495002

Stimulation of proliferation, differentiation, and function of human cells by primate interleukin 3.

A F Lopez, L B To, Y C Yang, J R Gamble, M F Shannon, G F Burns, P G Dyson, C A Juttner, S Clark, M A Vadas.   

Abstract

Cloned gibbon interleukin 3 (gIL-3) was found to stimulate the proliferation and differentiation of human bone marrow cells to produce day-14 granulocyte, macrophage, granulocyte-macrophage, and eosinophil colonies in semisolid agar. In the presence of normal human plasma, gIL-3 stimulated megakaryocytes. In methylcellulose cultures, it stimulated erythroid colonies in the presence, but not in the absence, of erythropoietin. When mature human leukocytes were used, gIL-3 stimulated the function of purified mature eosinophils as measured by the capacity to kill antibody-coated target cells, to produce superoxide anions, and to phagocytize opsonized yeast particles in a manner similar to recombinant human granulocyte-macrophage colony-stimulating factor. In contrast, gIL-3 did not significantly stimulate any of the neutrophil functions tested, whereas human recombinant granulocyte-macrophage colony-stimulating factor was active in these assays. Among cytokines that are active on human hematopoietic cells, gIL-3 thus has a distinct set of functions and may predict the range of actions of the human molecule.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3495002      PMCID: PMC304738          DOI: 10.1073/pnas.84.9.2761

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  25 in total

1.  Chemotaxis under agarose: a new and simple method for measuring chemotaxis and spontaneous migration of human polymorphonuclear leukocytes and monocytes.

Authors:  R D Nelson; P G Quie; R L Simmons
Journal:  J Immunol       Date:  1975-12       Impact factor: 5.422

2.  A new method for the purification of human eosinophils and neutrophils, and a comparison of the ability of these cells to damage schistosomula of Schistosoma mansoni.

Authors:  M A Vadas; J R David; A Butterworth; N T Pisani; T A Siongok
Journal:  J Immunol       Date:  1979-04       Impact factor: 5.422

3.  Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes).

Authors:  J L Cordell; B Falini; W N Erber; A K Ghosh; Z Abdulaziz; S MacDonald; K A Pulford; H Stein; D Y Mason
Journal:  J Histochem Cytochem       Date:  1984-02       Impact factor: 2.479

4.  Activation of antibody-dependent cell-mediated cytotoxicity of human neutrophils and eosinophils by separate colony-stimulating factors.

Authors:  M A Vadas; N A Nicola; D Metcalf
Journal:  J Immunol       Date:  1983-02       Impact factor: 5.422

5.  Human tumour necrosis factor: precursor structure, expression and homology to lymphotoxin.

Authors:  D Pennica; G E Nedwin; J S Hayflick; P H Seeburg; R Derynck; M A Palladino; W J Kohr; B B Aggarwal; D V Goeddel
Journal:  Nature       Date:  1984 Dec 20-1985 Jan 2       Impact factor: 49.962

6.  Molecular cloning of cDNA for murine interleukin-3.

Authors:  M C Fung; A J Hapel; S Ymer; D R Cohen; R M Johnson; H D Campbell; I G Young
Journal:  Nature       Date:  1984 Jan 19-25       Impact factor: 49.962

7.  Purification to apparent homogeneity of a factor stimulating the growth of multiple lineages of hemopoietic cells.

Authors:  I Clark-Lewis; S B Kent; J W Schrader
Journal:  J Biol Chem       Date:  1984-06-25       Impact factor: 5.157

8.  Mononuclear cell-mediated enhancement of granulocyte function in man.

Authors:  M A Vadas; N Nicola; A F Lopez; D Metcalf; G Johnson; A Pereira
Journal:  J Immunol       Date:  1984-07       Impact factor: 5.422

9.  Biologic properties of homogeneous interleukin 3. I. Demonstration of WEHI-3 growth factor activity, mast cell growth factor activity, p cell-stimulating factor activity, colony-stimulating factor activity, and histamine-producing cell-stimulating factor activity.

Authors:  J N Ihle; J Keller; S Oroszlan; L E Henderson; T D Copeland; F Fitch; M B Prystowsky; E Goldwasser; J W Schrader; E Palaszynski; M Dy; B Lebel
Journal:  J Immunol       Date:  1983-07       Impact factor: 5.422

10.  Enhancement of human eosinophil-mediated killing of Schistosoma mansoni larvae by mononuclear cell products in vitro.

Authors:  M C Veith; A E Butterworth
Journal:  J Exp Med       Date:  1983-06-01       Impact factor: 14.307

View more
  34 in total

Review 1.  Polypeptides controlling hematopoietic cell development and activation. I. In vitro results.

Authors:  F Herrmann; R Mertelsmann
Journal:  Blut       Date:  1989-03

2.  Transcriptional regulation of interleukin 3 gene expression in T lymphocytes.

Authors:  S G Shoemaker; R Hromas; K Kaushansky
Journal:  Proc Natl Acad Sci U S A       Date:  1990-12       Impact factor: 11.205

3.  Integrin-mediated protein kinase A activation at the leading edge of migrating cells.

Authors:  Chinten J Lim; Kristin H Kain; Eugene Tkachenko; Lawrence E Goldfinger; Edgar Gutierrez; Michael D Allen; Alex Groisman; Jin Zhang; Mark H Ginsberg
Journal:  Mol Biol Cell       Date:  2008-09-10       Impact factor: 4.138

4.  The effects of recombinant granulocyte-macrophage colony-stimulating factor (GM-CSF) and interleukin-3 on the secretory capacity of human blood eosinophils.

Authors:  P C Tai; C J Spry
Journal:  Clin Exp Immunol       Date:  1990-06       Impact factor: 4.330

5.  Reciprocal inhibition of binding between interleukin 3 and granulocyte-macrophage colony-stimulating factor to human eosinophils.

Authors:  A F Lopez; J M Eglinton; D Gillis; L S Park; S Clark; M A Vadas
Journal:  Proc Natl Acad Sci U S A       Date:  1989-09       Impact factor: 11.205

6.  IL-4 enhances IL-3 and IL-8 gene expression in a human leukemic mast cell line.

Authors:  M G Buckley; C M Williams; J Thompson; P Pryor; K Ray; J H Butterfield; J W Coleman
Journal:  Immunology       Date:  1995-03       Impact factor: 7.397

7.  Human interleukin-3 (IL-3) induces disulfide-linked IL-3 receptor alpha- and beta-chain heterodimerization, which is required for receptor activation but not high-affinity binding.

Authors:  F C Stomski; Q Sun; C J Bagley; J Woodcock; G Goodall; R K Andrews; M C Berndt; A F Lopez
Journal:  Mol Cell Biol       Date:  1996-06       Impact factor: 4.272

Review 8.  Why clinicians should be interested in interleukin-3.

Authors:  P Valent; K Geissler; C Sillaber; K Lechner; P Bettelheim
Journal:  Blut       Date:  1990-12

9.  Characterization and pharmacological modulation of antigen-induced peritonitis in actively sensitized mice.

Authors:  C Zuany-Amorim; D Leduc; B B Vargaftig; M Pretolani
Journal:  Br J Pharmacol       Date:  1993-10       Impact factor: 8.739

10.  Dysregulated hematopoiesis and a progressive neurological disorder induced by expression of an activated form of the human common beta chain in transgenic mice.

Authors:  R J D'Andrea; D Harrison-Findik; C M Butcher; J Finnie; P Blumbergs; P Bartley; M McCormack; K Jones; R Rowland; T J Gonda; M A Vadas
Journal:  J Clin Invest       Date:  1998-12-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.